53. シェーグレン症候群 Sjogren syndrome Clinical trials / Disease details

臨床試験数 : 305 / 薬物数 : 325 - (DrugBank : 104) / 標的遺伝子数 : 58 - 標的パスウェイ数 : 188

1 trial found

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05383677 (ClinicalTrials.gov)	October 1, 2022	29/3/2022	Anifrolumab Treatment for 24 Weeks in Patients With Primary Sjögren's Syndrome	ANIfrolumabTreatment for 24 Weeks in Patients With Primary Sjögren's Syndrome - Efficacy and Safety ...	Sjogren's Syndrome	Drug: Anifrolumab;Drug: Placebo	University Medical Center Groningen	AstraZeneca	Recruiting	18 Years	N/A	All	30	Phase 2	Netherlands

First Previous1Next Last